Pathology EMQ template.
Name: Tom MARJOT
Candidate number:
Theme: PANDEMIC FLU
OPTION LIST
|
A |
Neuraminidase |
I |
PB2 |
|
B |
Clara tryptase |
J |
RNA polymerase |
|
C |
Haemagglutinin |
K |
Furin |
|
D |
IFN-gamma |
L |
|
|
E |
Oseltamivir |
M |
|
|
F |
M2 |
N |
|
|
G |
Alpha 2,3 sialic acid |
O |
|
|
H |
Alpha 2,6 sialic acid |
P |
|
For each scenario below, choose the most appropriate answer from the list above. Each option may be used once, more than once or not at all.
1. A neuraminidase inhibitor, preventing new virion release from host cells; tradename ‘Tamiflu’
2. The target for the antiviral ‘amantadine’
3. A ubiquitous enzyme cleaving haemagglutanin which allows systemic dissemination of H5 and H7 influenza strains.
4. The major target for avian influenza allowing lower airways colonisation
5. A recombinant influenza vaccine, ACAM-FLU-A, holds the potential to protect against avian flu and new pandemics by using a component of what well conserved influenza protein?
ANSWERS
|
1. E |
2.F |
3. K |
4. G |
5. F |